MedTrace Logo

Lumbar Fusion With Nanotube Versus Titanium Cage

NCT07777718 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2026-08-21

No results posted yet for this study

Summary

This study is comparing two FDA-approved cages used during lower back surgery. The study will look at whether one cage helps the bones in the back fuse together better than the other. Adults who are having a 1 or 2 level lumbar fusion surgery will be randomly assigned to receive either the Adaptix nanoPEEK cage or the Capstone PTC cage. Participants will have follow-up visits with imaging and questionnaires to evaluate bone fusion, back and leg pain, physical function, and overall health.

Conditions

  • Degenerative Disc Disease
  • Lumbar Fusion

Interventions

DEVICE

Adaptix nanoPEEK Cage

FDA- approved interbody cage used during lumbar fusion surgery.

DEVICE

Capstone PTC Cage

FDA- approved interbody cage used during lumbar fusion surgery.

Sponsors & Collaborators

  • Francis Farhadi

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2028-04-30
Completion
2028-04-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07777718 on ClinicalTrials.gov